查看購物車
  • English
  • Japanese
  • Korean
RT-PCR市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告（按產品、應用及最終用戶分類）
市場調查報告書
商品編碼
1938275

RT-PCR市場規模及預測（2021-2031年），全球及區域佔有率、趨勢、成長機會分析報告（按產品、應用及最終用戶分類）

RT-PCR Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End user
出版日期: | 出版商: The Insight Partners | 英文 274 Pages | 訂單完成後即時交付

價格
根據我們最新的研究報告《RT-PCR市場預測至2031年－全球分析－按產品、應用和最終用戶分類》，RT-PCR市場規模預計將從2024年的27.1億美元成長到2031年的44.7億美元，2025年至2031年的複合年成長率為7.5% 。成長要素包括對高靈敏度和高準確度核酸檢測的需求、在臨床診斷和個人化醫療中不斷擴大的應用，以及RT-PCR技術和自動化的進步。

逆轉錄聚合酵素鏈鎖反應（RT-PCR）是一種實驗室技術，它透過逆轉錄將RNA轉化為互補DNA（cDNA），然後利用PCR技術進行擴增，從而檢測和定量RNA。由於其高靈敏度和特異性，RT-PCR被廣泛應用於病毒檢測、基因表現分析和分子診斷。在COVID-19疫情期間，RT-PCR在SARS-CoV-2感染的識別中發揮了關鍵作用。該技術能夠實現疾病的早期檢測、病毒量監測和基因活性研究，使其成為全球臨床診斷、生物醫學研究和公共衛生監測的重要工具。

RT-PCR市場報告的地理範圍涵蓋北美、歐洲、亞太、拉丁美洲以及中東和非洲的市場趨勢評估。北美RT-PCR市場主要受快速、準確診斷檢測的持續需求所驅動，尤其是在近期感染疾病爆發期間。美國疾病管制與預防中心（CDC）報告稱，截至2022年，美國新冠肺炎病例已超過1.2億例，凸顯了RT-PCR檢測在疫情管理中的關鍵作用。根據CDC和FDA的報告，新冠肺炎疫情將在2023年和2024年繼續影響檢測策略，預計每月將進行數百萬次檢測以監測和控制病毒傳播。此外，其他感染疾病（例如流感和呼吸道融合細胞病毒（RSV））發生率的上升也進一步推動了檢測需求。

RT-PCR市場展望預測，未來幾年亞太地區將實現最快成長，主要受感染疾病發病率上升和診斷技術進步的推動。世界衛生組織（世衛組織）預計，該地區2022年將報告約7億例感染疾病病例，由於都市化加快和人口密度增加，尤其是在印度和中國等國家，這一趨勢預計將持續下去。印度衛生與家庭福利部報告稱，2023年初新增新冠肺炎病例超過20萬例，凸顯了對有效診斷解決方案的持續需求。預計到2024年，對RT-PCR檢測的需求將持續存在，尤其是在呼吸道感染疾病仍是重大健康挑戰的情況下。

將RT-PCR技術應用於腫瘤學領域，以生物標記主導的個人化醫療，為未來的市場發展提供了機會。

根據世界衛生組織（WHO）的數據，預計2022年全球新增癌症病例將達2,000萬例，2023年將增加至2,030萬例，2024年將增加至2,050萬例。 RT-PCR技術能夠對60%的癌症病例進行基因分型，從而指導標靶治療。在美國，國家癌症研究所（NCI）報告稱，2022年新增癌症病例為190萬例，預計2023年將增至200萬例，2024年將增至204.1萬例。 RT-PCR技術在70%的精準醫療試驗中檢驗了生物標記。在歐洲，歐洲癌症資訊系統（ECIS）估計，2022年歐盟27國新增肺癌病例數將達274萬例，2023年將增加至278萬例，2024年將增加至282萬例。 RT-PCR技術可用於50%肺癌診斷中的基因融合檢測。

近期產品研發進展包括Guardant Health公司基於RT-PCR技術的液態生物檢體Guardant Reveal，該產品於2023年擴展了其腫瘤檢測範圍，並於2024年8月獲得FDA核准用於檢測大腸直腸癌復發。歐洲藥品管理局（EMA）也於2023年核准了羅氏公司基於RT-PCR技術的基因融合檢測產品FoundationOne CDx。其他例子包括美國國立衛生研究院（NIH）於2024年撥款2億美元用於精準腫瘤學研究。 2023年，500項研究檢驗了RT-PCR生物標記物，使標靶治療的準確性提高了25%。這些創新展現了RT-PCR在伴隨診斷領域的巨大潛力，並有助於推動個人化癌症治療的發展。

目錄

第1章 引言

第2章執行摘要

  • 主要發現

第3章調查方法

  • 調查範圍
  • 二次調查
  • 初步調查

第4章 RT-PCR市場概況

  • PEST分析
    • 世界PEST分析

第5章 RT-PCR市場－主要產業趨勢

  • 市場促進因素
    • 全球感染疾病激增，亟需快速診斷能力。
    • 癌症發生率的上升推動了癌症基因檢測和個人化診斷的發展。
    • 精準醫療和遺傳疾病基因檢測的進展
  • 市場限制
    • RT-PCR檢測套組高成本且供應有限
    • 供應鏈中斷以及試劑和耗材短缺
    • 監管方面的挑戰和漫長的核准流程
  • 市場機遇
    • 擴大照護現場，以快速應對感染疾病
    • 將RT-PCR技術應用於腫瘤學，邁向生物標記主導的個人化醫療
    • RT-PCR技術在基因篩檢和精準醫學的應用進展
  • 未來趨勢
    • 多重RT-PCR檢測方法的廣泛應用
    • 照護現場與可攜式RT-PCR設備整合
    • 自動化和高通量RT-PCR技術的進步
  • 影響分析

6. RT-PCR市場－全球市場分析

  • RT-PCR市場收入，2021-2031年

7. 全球RT-PCR市場－收入與預測－依產品分類

  • 2021年及2031年RT-PCR市場按產品分類的收入佔有率（%）
  • 試劑和耗材
  • 裝置
  • 軟體和服務

8. 全球RT-PCR市場－營收及至2031年預測－依應用領域分類

  • 2021年及2031年RT-PCR市場按應用領域分類的收入佔有率（%）
  • 研究用途
  • 臨床應用
  • 法醫學應用

9. 全球RT-PCR市場－收入及至2031年預測－依最終用戶分類

  • 按最終用戶分類的RT-PCR市場收入佔有率（2021年和2031年）（%）
  • 醫院和診斷中心
  • 製藥和生物技術公司
  • 研究和學術機構
  • 法醫學研究所
  • 臨床研究所

第10章 RT-PCR市場－區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區
  • 南美洲及中南美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區等地區

第11章：RT-PCR市場產業現狀

  • RT-PCR市場成長策略
  • 內部成長策略
  • 無機成長策略

第12章：公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific Inc
  • Takara Bio Inc
  • Qiagen NV
  • Hologic Inc
  • bioMerieux SALtd
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Agilent Technologies Inc
  • Promega CorpPvt Ltd

第13章附錄

Product Code: TIPRE00042220

According to our new research study on "RT-PCR Market Forecast to 2031 -Global Analysis - by Product, Application, and End User," the market is anticipated to grow from US$2.71 billion in 2024 to US$4.47 billion by 2031; the market is expected to register a CAGR of 7.5% from 2025 to 2031. The RT-PCR Market growth is attributed to the demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in RT-PCR technology and automation.

Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a laboratory technique used to detect and measure RNA by converting it into complementary DNA (cDNA) through reverse transcription, followed by amplification using PCR. It is widely used for viral detection, gene expression analysis, and molecular diagnostics because of its high sensitivity and specificity. RT-PCR played a critical role during the COVID-19 pandemic for identifying SARS-CoV-2 infections. The technique enables early disease detection, monitoring of viral load, and research into genetic activity, making it an essential tool in clinical diagnostics, biomedical research, and public health surveillance worldwide.

The geographical scope of the RT-PCR market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. The North America RT-PCR market is propelled by the ongoing demand for rapid and accurate diagnostic testing, especially highlighted by recent infectious disease outbreaks. In the US, the CDC reported over 120 million COVID-19 cases by 2022, emphasizing the crucial role of RT-PCR testing in managing the pandemic. According to the CDC and FDA reports, the prevalence of COVID-19 continued to influence testing strategies in 2023 and 2024, with estimates indicating that millions of tests were conducted monthly to monitor and control the virus's spread. Additionally, the increasing incidence of other infectious diseases, such as influenza and respiratory syncytial virus (RSV), has further boosted testing demand.

The RT-PCR market outlook indicates that Asia Pacific is expected to register the fastest growth in the coming years, supported by increasing incidence of infectious diseases and advancements in diagnostic technologies. According to the World Health Organization (WHO), the region reported nearly 700 million cases of infectious diseases in 2022, with projections indicating continued upward trends due to urbanization and population density, especially in countries such as India and China. In India, the Ministry of Health and Family Welfare reported over 200,000 new COVID-19 cases in early 2023, underlining the ongoing demand for effective diagnostic solutions. By 2024, the requirement for RT-PCR testing is expected to persist, particularly as respiratory infections continue to pose significant health challenges.

Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine to Provide Market Opportunities in Future

According to the World Health Organization (WHO), global cancer incidence reached 20 million new cases in 2022, rising to 20.3 million in 2023 and 20.5 million in 2024, with RT-PCR enabling oncogene profiling in 60% of cases for targeted therapies. In the US, the National Cancer Institute (NCI) reported 1.9 million new cases in 2022, increasing to 2.0 million in 2023 and 2.041 million in 2024, where RT-PCR validated biomarkers in 70% of precision trials. In Europe, the European Cancer Information System (ECIS) estimated 2.74 million new cases in the EU-27 in 2022, rising to 2.78 million in 2023 and 2.82 million in 2024, with RT-PCR facilitating gene fusion testing in 50% of lung cancer diagnoses.

Recent product developments include the FDA's approval of Guardant Health's Guardant Reveal, an RT-PCR-based liquid biopsy for detecting colorectal cancer recurrence, in August 2024, following the company's oncology panel expansion in 2023. Additionally, the European Medicines Agency (EMA) authorized Roche's FoundationOne CDx in 2023 for RT-PCR-based gene fusion testing. Other instances encompass the NIH's 2024 allocation of US$200 million for precision oncology, where RT-PCR validated biomarkers in 500 studies in 2023, improving targeted therapy accuracy by 25%. These innovations present opportunities for RT-PCR in companion diagnostics, advancing tailored cancer care.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the RT-PCR Market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. RT-PCR Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. RT-PCR Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Surging Global Infectious Disease Outbreaks Necessitating Rapid Diagnostic Capabilities
    • 5.1.2 Escalating Cancer Incidence Driving Oncogene Detection and Personalized Diagnostics
    • 5.1.3 Advancing Genetic Testing for Precision Medicine and Hereditary Disorders
  • 5.2 Market Restraints
    • 5.2.1 High Costs and Limited Accessibility of RT-PCR Testing Kits
    • 5.2.2 Supply Chain Disruptions and Shortage of Reagents and Consumables
    • 5.2.3 Regulatory Challenges and Lengthy Approval Processes
  • 5.3 Market Opportunities
    • 5.3.1 Expansion in Point-of-Care RT-PCR for Rapid Infectious Disease Response
    • 5.3.2 Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine
    • 5.3.3 Advancements in RT-PCR for Genetic Screening and Precision Health
  • 5.4 Future Trends
    • 5.4.1 Increasing Adoption of Multiplex RT-PCR Assays
    • 5.4.2 Integration of Point-of-Care and Portable RT-PCR Devices
    • 5.4.3 Advances in Automated and High-Throughput RT-PCR Technologies
  • 5.5 Impact Analysis:

6. RT-PCR Market - Global Market Analysis

  • 6.1 RT-PCR Market Revenue (US$ Mn), 2021 - 2031

7. Global RT-PCR Market - Revenue and Forecast to 2031 - by Product

  • 7.1 Overview
  • 7.2 RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
  • 7.3 Reagents & Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents & Consumables: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Software & Services
    • 7.5.1 Overview
    • 7.5.2 Software & Services: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)

8. Global RT-PCR Market - Revenue and Forecast to 2031 - by Application

  • 8.1 Overview
  • 8.2 RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
  • 8.3 Research Application
    • 8.3.1 Overview
    • 8.3.2 Research Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Clinical Application
    • 8.4.1 Overview
    • 8.4.2 Clinical Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
      • 8.4.2.1 RT-PCR Market, by Clinical Application, 2021-2031 (US$ Million)
  • 8.5 Forensic Application
    • 8.5.1 Overview
    • 8.5.2 Forensic Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)

9. Global RT-PCR Market - Revenue and Forecast to 2031 - by End-User

  • 9.1 Overview
  • 9.2 RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Overview
    • 9.4.2 Pharmaceutical and Biotechnology Companies: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Research Laboratories and Academic Institutes
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories and Academic Institutes: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Forensic Laboratories
    • 9.6.1 Overview
    • 9.6.2 Forensic Laboratories: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Clinical Research Organizations
    • 9.7.1 Overview
    • 9.7.2 Clinical Research Organizations: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)

10. RT-PCR Market - Geographical Analysis

  • 10.1 North America RT-PCR Market, Revenue and Forecast To 2031
    • 10.1.1 Overview
    • 10.1.2 North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.1.3 North America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
    • 10.1.4 North America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
      • 10.1.4.1 North America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.1.5 North America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.1 North America RT-PCR Market, by Country
      • 10.1.5.2 US
        • 10.1.5.2.1 US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.2.2 US: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.2.3 US: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.2.4.1 US: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.2.5 US: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.3 Canada
        • 10.1.5.3.1 Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.3.2 Canada: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.3.3 Canada: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.3.4.1 Canada: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.3.5 Canada: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.1.5.4 Mexico
        • 10.1.5.4.1 Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.1.5.4.2 Mexico: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.1.5.4.3 Mexico: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.1.5.4.3.1 Mexico: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.1.5.4.4 Mexico: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.2 Europe RT-PCR Market, Revenue and Forecast to 2031
    • 10.2.1 Overview
    • 10.2.2 Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.2.3 Europe: RT-PCR Market, by Product, 2021-2031 (US$ Million)
    • 10.2.4 Europe: RT-PCR Market, by Application, 2021-2031 (US$ Million)
      • 10.2.4.1 Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.2.5 Europe: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.1 Europe RT-PCR Market, by Country
      • 10.2.5.2 UK
        • 10.2.5.2.1 UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.2.2 UK: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.2.3 UK: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.2.3.1 UK: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.2.4 UK: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.3 Germany
        • 10.2.5.3.1 Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.3.2 Germany: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.3.3 Germany: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.3.3.1 Germany: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.3.4 Germany: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.4 France
        • 10.2.5.4.1 France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.4.2 France: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.4.3 France: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.4.3.1 France: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.4.4 France: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.5 Italy
        • 10.2.5.5.1 Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.5.2 Italy: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.5.3 Italy: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.5.3.1 Italy: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.5.4 Italy: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.6 Spain
        • 10.2.5.6.1 Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.6.2 Spain: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.6.3 Spain: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.6.3.1 Spain: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.3.5 Spain: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.2.5.7 Rest of Europe
        • 10.2.5.7.1 Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.2.5.7.2 Rest of Europe: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.2.5.7.3 Rest of Europe: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.2.5.7.3.1 Rest of Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.2.5.7.4 Rest of Europe: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.3 Asia Pacific RT-PCR Market, Revenue and Forecast to 2031
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.3.3 Asia Pacific: RT-PCR Market, by Product, 2021-2031 (US$ Million)
    • 10.3.4 Asia Pacific: RT-PCR Market, by Application, 2021-2031 (US$ Million)
      • 10.3.4.1 Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.3.5 Asia Pacific: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.1 Asia Pacific RT-PCR Market, by Country
      • 10.3.5.2 China
        • 10.3.5.2.1 China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.2.2 China: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.2.3 China: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.2.3.1 China: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.2.4 China: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.3 Japan
        • 10.3.5.3.1 Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.3.2 Japan: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.3.3 Japan: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.3.3.1 Japan: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.3.4 Japan: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.4 India
        • 10.3.5.4.1 India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.4.2 India: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.4.3 India: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.4.3.1 India: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.4.4 India: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.5 Australia
        • 10.3.5.5.1 Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.5.2 Australia: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.5.3 Australia: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.5.3.1 Australia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.5.4 Australia: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.6 South Korea
        • 10.3.5.6.1 South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.6.2 South Korea: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.6.3 South Korea: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.6.3.1 South Korea: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.6.4 South Korea: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.7 Rest of Asia Pacific
        • 10.3.5.7.1 Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.7.2 Rest of Asia Pacific: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.7.3 Rest of Asia Pacific: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.7.3.1 Rest of Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.7.4 Rest of Asia Pacific: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.4 Middle East & Africa RT-PCR Market, Revenue and Forecast to 2031
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.4.3 Middle East & Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
    • 10.4.4 Middle East & Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
      • 10.4.4.1 Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.4.5 Middle East & Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.1 Middle East & Africa RT-PCR Market, by Country
      • 10.3.5.2 Saudi Arabia
        • 10.3.5.2.1 Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.2.2 Saudi Arabia: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.2.3 Saudi Arabia: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.2.3.1 Saudi Arabia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.2.4 Saudi Arabia: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.3 UAE
        • 10.3.5.3.1 UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.3.2 UAE: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.3.3 UAE: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.3.3.1 UAE: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.3.5 UAE: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.4 South Africa
        • 10.3.5.4.1 South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.4.2 South Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.4.3 South Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.4.3.1 South Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.4.4 South Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.3.5.5 Rest of Middle East & Africa
        • 10.3.5.5.1 Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.3.5.5.2 Rest of Middle East & Africa: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.3.5.5.3 Rest of Middle East & Africa: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.3.5.5.3.1 Rest of Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.3.5.5.4 Rest of Middle East & Africa: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
  • 10.5 South & Central America RT-PCR Market, Revenue and Forecast to 2031
    • 10.5.1 Overview
    • 10.5.2 South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
    • 10.5.3 South & Central America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
    • 10.5.4 South & Central America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
      • 10.5.4.1 South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
    • 10.5.5 South & Central America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.1 South & Central America RT-PCR Market, by Country
      • 10.5.5.2 Brazil
        • 10.5.5.2.1 Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.2.2 Brazil: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.2.3 Brazil: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.2.3.1 Brazil: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.2.4 Brazil: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.3 Argentina
        • 10.5.5.3.1 Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.3.2 Argentina: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.3.3 Argentina: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.3.3.1 Argentina: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.3.4 Argentina: RT-PCR Market, by End-User, 2021-2031 (US$ Million)
      • 10.5.5.4 Rest of South & Central America
        • 10.5.5.4.1 Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
        • 10.5.5.4.2 Rest of South & Central America: RT-PCR Market, by Product, 2021-2031 (US$ Million)
        • 10.5.5.4.3 Rest of South & Central America: RT-PCR Market, by Application, 2021-2031 (US$ Million)
          • 10.5.5.4.3.1 Rest of South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
        • 10.5.5.4.4 Rest of South & Central America: RT-PCR Market, by End-User, 2021-2031 (US$ Million)

11. RT-PCR Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in RT-PCR Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Thermo Fisher Scientific Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Takara Bio Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Qiagen NV
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hologic Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 bioMerieux SALtd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 F. Hoffmann-La Roche Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Bio-Rad Laboratories Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Agilent Technologies Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Promega CorpPvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 SWOT Analysis
    • 12.10.5 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. RT-PCR Market Segmentation
  • Table 2. RT-PCR Market, by Clinical Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. North America RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. North America RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 5. North America RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 6. North America RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 7. US RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 8. US RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 9. US RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 10. US RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 11. Canada RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 12. Canada RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 13. Canada RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 14. Canada RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 15. Mexico RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 16. Mexico RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 17. Mexico RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 18. Mexico RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 19. Europe RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 20. Europe RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 21. Europe RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 22. Europe RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 23. UK RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 24. UK RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 25. UK RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 26. UK RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 27. Germany RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 28. Germany RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 29. Germany RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 30. Germany RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 31. France RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 32. France RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 33. France RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 34. France RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 35. Italy RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 36. Italy RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 37. Italy RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 38. Italy RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 39. Spain RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 40. Spain RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 41. Spain RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 42. Spain RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 43. Rest of Europe RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 44. Rest of Europe RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 45. Rest of Europe RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 46. Rest of Europe RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 47. Asia Pacific RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 48. Asia Pacific RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 49. Asia Pacific RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 50. Asia Pacific RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 51. China RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 52. China RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 53. China RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 54. China RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 55. Japan RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 56. Japan RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 57. Japan RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 58. Japan RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 59. India RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 60. India RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 61. India RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 62. India RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 63. Australia RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 64. Australia RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 65. Australia RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 66. Australia RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 67. South Korea RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 68. South Korea RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 69. South Korea RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 70. South Korea RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 71. Rest of Asia Pacific RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 72. Rest of Asia Pacific RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 73. Rest of Asia Pacific RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 74. Rest of Asia Pacific RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 75. Middle East & Africa RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 76. Middle East & Africa RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 77. Middle East & Africa RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 78. Middle East & Africa RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 79. Saudi Arabia RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 80. Saudi Arabia RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 81. Saudi Arabia RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 82. Saudi Arabia RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 83. UAE RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 84. UAE RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 85. UAE RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 86. UAE RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 87. South Africa RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 88. South Africa RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 89. South Africa RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 90. South Africa RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 91. Rest of Middle East & Africa RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 92. Rest of Middle East & Africa RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 93. Rest of Middle East & Africa RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 94. Rest of Middle East & Africa RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 95. South & Central America RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 96. South & Central America RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 97. South & Central America RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 98. South & Central America RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 99. Brazil RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 91. Brazil RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 92. Brazil RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 93. Brazil RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 94. Argentina RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 95. Argentina RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 96. Argentina RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 97. Argentina RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 98. Rest of South & Central America RT-PCR Market, by Product - Revenue and Forecast to 2031 (US$ Million)
  • Table 99. Rest of South & Central America RT-PCR Market, by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 100. Rest of South & Central America RT-PCR Market, for Clinical Application by Application - Revenue and Forecast to 2031 (US$ Million)
  • Table 101. Rest of South & Central America RT-PCR Market, by End-User - Revenue and Forecast to 2031 (US$ Million)
  • Table 102. Recent Organic Growth Strategies in RT-PCR Market
  • Table 103. Recent Inorganic Growth Strategies in the RT-PCR Market
  • Table 104. Glossary of Terms, RT-PCR Market

List Of Figures

  • Figure 1. RT-PCR Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. RT-PCR Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. RT-PCR Market Revenue (US$ Mn), 2021 - 2031
  • Figure 6. RT-PCR Market Revenue, Geography (US$ Mn), 2021 - 2031
  • Figure 7. Quantitative PCR: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Digital PCR: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
  • Figure 10. Reagents & Consumables: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Instruments: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Software & Services: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
  • Figure 14. Research Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Clinical Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Forensic Application: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
  • Figure 18. Hospitals and Diagnostic Centers: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Pharmaceutical and Biotechnology Companies: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Research Laboratories and Academic Institutes: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Forensic Laboratories: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Clinical Research Organizations: RT-PCR Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America: RT-PCR Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 25. North America RT-PCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 26. US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 27. Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 28. Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 29. Europe RT-PCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 30. Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 31. Europe RT-PCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 32. UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 33. Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 34. France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 35. Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 36. Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 37. Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 38. Asia Pacific RT-PCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 39. Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 40. Asia Pacific RT-PCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 41. China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 42. Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 43. India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 44. Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 45. South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 46. Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 47. Middle East & Africa RT-PCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 48. Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 49. Middle East & Africa RT-PCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 50. Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 51. UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 52. South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 53. Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 54. South & Central America RT-PCR Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 55. South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 56. South & Central America RT-PCR Market, By Key Countries, 2022 and 2031 (%)
  • Figure 57. Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 58. Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 59. Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
  • Figure 60. Growth Strategies in RT-PCR Market